Global: Asian markets mostly ended lower on fears of the 2nd wave of coronavirus infections as more countries gradually re-open their economies. The sentiment was also dampened by heightened US-China tension after Trump said he opposed renegotiating the "Phase 1" trade deal with China. Overnight, Dow slumped 457 pts or 1.9% to 23764 amid worries over rushed reopening could spark a second wave of infections and inflict further economic damage, following a warning by Dr. Anthony Fauci that the virus is not under control yet.
Malaysia: Tracking shaky regional markets, KLCI eased 2.4 pts at 1379.9 ahead of the 1Q20 GDP today and potential no-confidence motion against the PM (on 18 May or the next Parliament sitting 13-29 July). Trading volume increased to 6.39bn shares worth RM3.73bn as compared to Friday’s 4.68bn shares worth RM2.74bn, led by active buying interests on healthcare-related stocks after WHO warns that coronavirus cases have jumped in countries that eased lockdowns prematurely.
In the absence of rerating catalysts, KLCI is expected to trend sideways with immediate support at 1370 (50D SMA). A firm close below the 50D SMA would put the bears in the driving seat again, where the index may fall to 1359 (22 Apr low) and 1340-1350 thereafter. Conversely, a strong breakout above double resistances at 1418 (18 Apr) and 1429 (20 Apr) would then revive the bulls from 1208 low (19 Mar) to re-challenge 1456 (20W SMA) and 1468 (100D SMA) zones.
Following a 14.4% relief rally from its low of 1208 (19 Mar), KLCI could experience some degree of profit taking, ahead of the 1Q20 GDP release today and expectations of a tepid 1Q20 results season coupled with concerns over potential no-confidence motion against the PM (on 18 May or the next Parliament sitting 13-29 July). We expect more range bound consolidation within 1350-1400 band.
Source: Hong Leong Investment Bank Research - 13 May 2020
Chart | Stock Name | Last | Change | Volume |
---|
2024-07-29
FOCUSP2024-07-27
ECONBHD2024-07-27
GADANG2024-07-27
PHARMA2024-07-26
INARI2024-07-26
INARI2024-07-26
INARI2024-07-26
INARI2024-07-26
INARI2024-07-25
GADANG2024-07-25
GADANG2024-07-25
GADANG2024-07-25
GADANG2024-07-25
INARI2024-07-25
INARI2024-07-25
INARI2024-07-25
TALIWRK2024-07-25
TALIWRK2024-07-25
TALIWRK2024-07-25
TALIWRK2024-07-25
TALIWRK2024-07-25
TALIWRK2024-07-25
TALIWRK2024-07-25
TALIWRK2024-07-25
TALIWRK2024-07-24
INARI2024-07-24
INARI2024-07-24
UNISEM2024-07-23
FOCUSP2024-07-23
FOCUSP2024-07-23
INARI2024-07-23
INARI2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-23
TALIWRK2024-07-22
FOCUSP2024-07-22
INARI2024-07-22
INARI2024-07-22
INARI2024-07-22
INARI2024-07-22
INARI2024-07-19
EDGENTA2024-07-19
EDGENTA2024-07-19
EDGENTA2024-07-19
GADANG2024-07-19
GADANG2024-07-19
INARI2024-07-19
INARI2024-07-19
INARI2024-07-19
INARI2024-07-19
INARI2024-07-19
INARI2024-07-19
MEDIA2024-07-19
PHARMA2024-07-18
ECONBHD2024-07-18
ECONBHD2024-07-18
ECONBHD2024-07-18
INARI2024-07-18
INARI2024-07-18
INARI2024-07-18
INARI2024-07-17
ECONBHD2024-07-17
GBGAQRS2024-07-17
GBGAQRS2024-07-17
INARI2024-07-16
ECONBHD2024-07-16
GBGAQRS2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
INARI2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRK2024-07-16
TALIWRKCreated by HLInvest | Jul 19, 2024